Biosan Laboratories

Clinlogix is a Global Clinical Research Service & Consulting Organization working to improve human quality of life by supporting innovation in the life science industry. Its full suite of clinical research services supports the regulatory and clinical development pathway of medical devices, pharmaceuticals, biologics and diagnostics from proof of concept/discovery, early feasibility/first-in-human, through pivotal and the post-marketing/safety surveillance of client products. The company delivers this global expertise by way of its regional office locations in the US - Spring House, Pennsylvania, Europe - Mainz, Germany, Latin America - Medellin, Colombia and Asia Pacific - Tokyo, Japan.

Biocartis is an innovative commercial stage molecular diagnostics (MDx) company providing next generation diagnostic solutions aimed at improving clinical practice for the benefit of patients, clinicians, payers and industry. Our proprietary MDx Idylla™ platform is a fully automated, real time system which offers accurate, highly-reliable molecular information from any biological sample in virtually any setting. Idylla™ addresses the growing demand for personalized medicine by allowing fast and effective treatment selection and treatment progress monitoring.

Biocartis is developing and marketing a rapidly expanding test menu addressing key unmet clinical needs in oncology and infectious diseases. These areas represent respectively the fastest and largest growing segments of the US$6.5 billion molecular diagnostics market. Biocartis employs over 500 people and is headquartered in Mechelen, Belgium. Further information? Visit www.biocartis.com

BioTX Automation, Inc. engages in the development, manufacture, and marketing of personal automation tools for use with reagent kits, and for error elimination in forensic, life sciences research, drug discovery, microarray, and diagnostics labs, as well as biological product manufacturers. BioTX operates in three market segments, Lab Products, Custom Automation and Marketing Tools. The Lab Product segment provides personal automation systems for the eradication of Fillaphobia (the fear of putting the wrong sample into the wrong well of a microplate) in DNA forensic, molecular biology, cell biology, and drug discovery labs. The Custom Automation product line includes rapid prototyped tools used with robots to automate various lab protocols. In addition, this segment provides custom engineering and instrument integration services. We have developed robotic tooling for blood card punching and Petri dish plating. The Marketing Tools segment offers an on-line web based searchable database of life sciences researchers, as well as researcher lists by keyword and emailing services for companies that sell to life science researchers. The company offers its products to the life sciences research market and the biopharmaceutical production market directly, and through distributors or agents in approximately 6 countries. BioTX was founded in 2003 and is based 35 miles north of Houston in Conroe, Texas.

Clara Diagnostics is developing the Exosome Sorting System (ExoSS), a high-throughput microfluidic system for the isolation and purification of exosomes. The company aims to launch the first microfluidic exosome sorting device (ExoSS) into the marketplace for automated, high-specificity, and high throughput preparation of exact exosome subtypes from a variety of biofluids.
The ExoSS system performs isolation 100x faster than ultracentrifugation and able to extract greater than 90% of exosomes with an isolation purity greater than 90%. ExoSS rapidly runs parallel samples continuously, resulting in a platform ideal for large volume processing. Designed for low skill automation, ExoSS has the advantage of extracting all or only specific
types of exosomes from the biological source.
An On Site Non-Clinical Isolation Service (ExoSS OnSite) was launched in November 2018 by the company utilizing the existing ExoSS system.
Clara Diagnostics is focused on establishing strategic partnerships for development in diagnostic and therapeutic applications, equipment manufacturing, antibody sourcing, distribution, sales and marketing.

Specializing in the development and manufacture of innovative prescription and over-the-counter (OTC) therapies, privately held Fleming Pharmaceuticals is the proud maker of MAGONATE®, NEPHROCAPS®, NEPHROCAPS® QT, ThyroShield®, ProBarimin QT® and the OCEAN® Nasal Care line of products.

Established in 1960, the company has developed products for a variety of clinical conditions in allergy, pediatrics, nephrology, nutrition, and obstetrics/gynecology.

Based in the greater St. Louis area, our fully integrated headquarter facility houses state-of-the-art liquid and solid pharmaceutical manufacturing and packaging, analytical microbiological laboratories, research and development, distribution, marketing, and business administration functions.